We are live on ! Find out more
PD

Point72 (DIFC) Portfolio holdings

AUM $1.53B
1-Year Est. Return 15.83%
This Fund
S&P 500
This Quarter Est. Return
+11.22%
1 Year Est. Return
+15.83%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.64B
AUM Growth
+$206M
Cap. Flow
-$30.6M
Cap. Flow %
-1.16%
Top 10 Hldgs %
20.71%
Holding
2,202
New
586
Increased
360
Reduced
541
Closed
708

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$21.9M
2
PM icon
Philip Morris
PM
+$20.8M
3
GE icon
GE Aerospace
GE
+$19.6M
4
CRH icon
CRH
CRH
+$19M
5
ABBV icon
AbbVie
ABBV
+$17.4M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$24.8M
2
CSCO icon
Cisco
CSCO
+$17.7M
3
QGEN icon
Qiagen
QGEN
+$14M
4
AVGO icon
Broadcom
AVGO
+$14M
5
SNOW icon
Snowflake
SNOW
+$14M

Sector Composition

Rank Sector Weight
1 Healthcare 13.75%
2 Technology 10.49%
3 Financials 6.05%
4 Industrials 4.83%
5 Consumer Discretionary 3.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MYFW icon
1426
First Western Financial
MYFW
$304M
$1.8K ﹤0.01%
+80
New +$1.65K
MATV icon
1427
Mativ Holdings
MATV
$481M
$1.79K ﹤0.01%
263
-15,970
-98% -$92K
TLS icon
1428
Telos
TLS
$332M
$1.57K ﹤0.01%
+496
New +$1.29K
BCAL icon
1429
Southern California Bancorp
BCAL
$684M
$1.32K ﹤0.01%
+84
New +$1.2K
YMAB
1430
DELISTED
Y-mAbs Therapeutics
YMAB
$1.29K ﹤0.01%
287
-4,771
-94% -$21.4K
UNTY icon
1431
Unity Bancorp
UNTY
$591M
$1.22K ﹤0.01%
+26
New +$1.12K
ALTO icon
1432
Alto Ingredients
ALTO
$369M
$1.15K ﹤0.01%
1,003
+270
+37% +$259
MDGL icon
1433
Madrigal Pharmaceuticals
MDGL
$10.8B
$1.13K ﹤0.01%
+4
New +$1.19K
IPSC icon
1434
Century Therapeutics
IPSC
$364M
$977 ﹤0.01%
+1,749
New +$938
ZYME icon
1435
Zymeworks
ZYME
$1.61B
$966 ﹤0.01%
+77
New +$917
OBIO icon
1436
Orchestra BioMed
OBIO
$238M
$949 ﹤0.01%
+354
New +$1.03K
CBUS icon
1437
Cibus
CBUS
$147M
$934 ﹤0.01%
+677
New +$1.38K
FLGT icon
1438
Fulgent Genetics
FLGT
$470M
$934 ﹤0.01%
47
-7,339
-99% -$143K
STTK icon
1439
Shattuck Labs
STTK
$675M
$863 ﹤0.01%
+1,090
New +$1.06K
NMRA icon
1440
Neumora Therapeutics
NMRA
$298M
$821 ﹤0.01%
+1,119
New +$848
DHX icon
1441
DHI Group
DHX
$182M
$808 ﹤0.01%
272
-103
-27% -$199
CPS icon
1442
Cooper-Standard Automotive
CPS
$523M
$796 ﹤0.01%
37
-1,710
-98% -$32.9K
VRDN icon
1443
Viridian Therapeutics
VRDN
$2.09B
$761 ﹤0.01%
54
-4,719
-99% -$64K
CADL icon
1444
Candel Therapeutics
CADL
$733M
$740 ﹤0.01%
+146
New +$751
SEER icon
1445
Seer Inc
SEER
$122M
$710 ﹤0.01%
332
-80
-19% -$160
FORR icon
1446
Forrester Research
FORR
$223M
$703 ﹤0.01%
+71
New +$706
GUTS icon
1447
Fractyl Health
GUTS
$109M
$700 ﹤0.01%
+432
New +$698
GNLX icon
1448
Genelux
GNLX
$132M
$695 ﹤0.01%
242
+94
+64% +$248
LNAI
1449
Lunai Bioworks
LNAI
$8.8M
$683 ﹤0.01%
+30
New +$838
VMD icon
1450
Viemed Healthcare
VMD
$447M
$649 ﹤0.01%
94
-1,190
-93% -$8.08K
56 57
58
59 60

Similar funds

HT
HAP Trading New York $1.42B AUM 41.92% 1-Year Est. Return
SIMG
Sonora Investment Management Group Tucson, Arizona $1.41B AUM 20.58% 1-Year Est. Return
4CM
400 Capital Management New York $1.4B AUM
SAM
Scion Asset Management Saratoga, California $1.38B AUM 43.96% 1-Year Est. Return
CCB
Country Club Bank Kansas City, Missouri $1.69B AUM 16.93% 1-Year Est. Return
SFI
SPC Financial Inc Rockville, Maryland $1.28B AUM 12.6% 1-Year Est. Return
P
Pitcairn Conshohocken, Pennsylvania $1.27B AUM 23.64% 1-Year Est. Return
FSC
Full Sail Capital Oklahoma City, Oklahoma $1.81B AUM 10.99% 1-Year Est. Return

Point72 (DIFC)'s Q2 2025 Portfolio in Review

As of Q2 2025, Point72 (DIFC) held 2,202 positions worth $2.64B, up 8.4% from $2.44B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Point72 (DIFC)'s Q2 2025 filing shows 586 new, 360 increased, 541 reduced and 708 closed positions. Its largest new stake was Thermo Fisher Scientific: 52,494 shares worth $21.3M. The largest sale was Meta Platforms (Facebook), an estimated $24.8M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.

  • Point72 (DIFC)'s largest Q2 2025 buy was Thermo Fisher Scientific: 52,494 shares worth $21.3M.
  • Point72 (DIFC) added most to CRH in Q2 2025, an estimated $19M increase.
  • Point72 (DIFC)'s biggest Q2 2025 reduction was Meta Platforms (Facebook), cutting an estimated $24.8M.
  • Point72 (DIFC) fully exited Cisco in Q2 2025, selling an estimated $17.7M.
  • Point72 (DIFC)'s ten largest holdings make up 21% of its $2.64B portfolio in Q2 2025.
  • Point72 (DIFC) opened 586 new positions and closed 708 in Q2 2025.
  • Point72 (DIFC)'s portfolio value rose 8.4% quarter-over-quarter to $2.64B.

Based on Point72 (DIFC)'s 13F filing for Q2 2025, filed 14 Aug 2025.